Lung-Function Response To Tiotropium plus Olodaterol In Patients With COPD With β-Agonist Reversibility

被引：0
|
作者：
Tashkin, D. P. [1 ]
Ferguson, G. T. [2 ]
Clerisme-Beaty, E. [3 ]
Vob, F. [4 ]
Buhl, R. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6808
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment With Tiotropium Plus Olodaterol Respimat Improves Physical Functioning Of COPD Patients In A Real Life Setting
    Haensel, M.
    Glaab, T.
    Sauer, R.
    Rubin, R.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [22] Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
    Takahashi, Koichiro
    Uchida, Masaru
    Kato, Go
    Takamori, Ayako
    Sadamatsu, Hironori
    Tanaka, Masahide
    Tajiri, Ryo
    Kinoshita, Takashi
    Kojima, Keisuke
    Yoshida, Makoto
    Tashiro, Hiroki
    Hayashi, Shinichiro
    Kawaguchi, Atsushi
    Sueoka-Aragane, Naoko
    Kawayama, Tomotaka
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD
    Ferguson, Gary T.
    Pizzichini, Emilio
    Flezar, Matjaz
    Groenke, Lars
    Korducki, Lawrence
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [24] Tiotropium/Olodaterol Improves Pulmonary Function and Physical Activity in Patients with Treatment-Naive COPD
    Takahashi, K.
    Uchida, M.
    Kato, G.
    Takamori, A.
    Sadamatsu, H.
    Tanaka, M.
    Tajiri, R.
    Inoue, H.
    Kinoshita, T.
    Kojima, K.
    Yoshida, M.
    Kobayashi, H.
    Tashiro, H.
    Hayashi, S.
    Kawaguchi, A.
    Sueoka-Aragane, N.
    Kawayama, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] TIOTROPIUM/OLODATEROL THERAPY IMPROVES LUNG FUNCTION, SYMPTOMS AND IMPACT OF DISEASE VS MONOTHERAPIES IN STEROID-FREE PATIENTS WITH COPD
    Calverley, Peter
    de la Hoz, Alberto
    Xue, Wenqiong
    Ferguson, Gary
    Miravitlles, Marc
    CHEST, 2019, 156 (04) : 2278A - 2279A
  • [26] Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone
    Kurashima, Kazuyoshi
    Hara, Kenichirou
    Yoneda, Kouichirou
    Kanauchi, Tetsu
    Kagiyama, Naho
    Tokunaga, Daido
    Takayanagi, Noboru
    Ubukata, Mikio
    Sugita, Yutaka
    RESPIROLOGY, 2009, 14 (02) : 239 - 244
  • [27] Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD
    Berton, Danilo C.
    Marques, Renata D.
    Palmer, Brandon
    O'Donnell, Denis E.
    Neder, J. Alberto
    RESPIRATORY MEDICINE, 2019, 157 : 59 - 68
  • [28] Tiotropium plus Olodaterol Therapy Provides Lung-Function Benefits Over Salmeterol plus Fluticasone Propionate Irrespective Of Prior Ics Treatment: Post Hoc Analyses Of The Energito® Study
    Derom, E.
    Clerisme-Beaty, E.
    Gronke, L.
    Voss, F.
    Zhai, D.
    Bjermer, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] Benefits of Tiotropium/Olodaterol Over Tiotropium Alone in Delaying Clinically Significant Deterioration in Patients with COPD
    Rabe, K. F.
    Chalmers, J. D.
    Miravitlles, M.
    Kocks, J.
    Tsiligianni, I.
    de la Hoz, A.
    Xue, W.
    Wedzicha, J. A.
    Singh, D.
    Ferguson, G. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [30] EFFICACY OF TIOTROPIUM AND OLODATEROL COMBINATION IN PATIENTS WITH COPD ON beta-BLOCKERS
    Derom, E.
    Korn, S.
    Hamilton, A.
    Amatto, V. C.
    Zhao, Y.
    Maltais, F.
    THORAX, 2015, 70 : A142 - A142
12345